Bye bye, bifocals? New eye drops can fix farsightedness
Posted:
The US Food and Drug Administration has approved the first eye drop that could allow users to ditch their bifocals—or at least rely on them far less often. Developed by the pharmaceutical company LENZ, VIZZ is an aceclidine ophthalmic treatment in the form of once-daily drops that ease near-object blurriness for up to 10 hours.
A study suggests that artificial intelligence (AI) showed comparable performance to dermatologists in detecting melanoma, with similar sensitivity and specificity in prospective clinical studies.
Experts often consider melanoma to be the most serious type of skin cancer due to the likelihood of metastasizing.
Read more here.
The further Apple dives into medical technology, the more it will have to deal with regulators. Now, the App Store will label apps that meet select criteria for medical devices in the US, EU, and UK.
Read more here.
Attendees
Sponsors and Exhibitors
Contact us